This week, we will discuss the use of renal autologous cell therapy (REACT) in diabetic kidney disease.
This week, we will discuss 2026 KDIGO anemia management in patients with kidney disease
This week, we aim for an INFINITe allograft lifespan. or flozination in kidney transplant.
This week, we will discuss the POTCAST trial. It is a cardiology trial - but potassium belongs to nephrology.
Itunu Owoyemi discusses use of a needle core biopsy to diagnose CUA in a dialysis patients. What are the implications of bringing this technique to this difficult to diagnose disease?
